Healthcare professionals can make false assumptions about which children with type 1 diabetes will gain most from closed-loop insulin delivery, risking children who could potentially benefit missing out, research suggests.
Around one in 300 children aged 2–5 years from the general population may be positive for islet autoantibodies on screening and therefore have presymptomatic type 1 diabetes, results of the Fr1da study suggest.
Children with type 1 diabetes have increased activation of certain areas of the brain during attention-demanding tasks, which may compensate for diabetes-related impairments and bring their cognitive ability in line with peers without diabetes, report researchers.
The setting in which children with newly diagnosed type 1 diabetes initiate their care makes no significant difference to glucose control, psychologic outcomes, or the rate of adverse events, shows a UK study comparing home and hospital options.
Islet autoantibody negativity plus mild hyperglycemia and a family history of diabetes can be used to identify children newly diagnosed with diabetes who should undergo genetic testing for maturity-onset diabetes of the young, study findings indicate.
People with type 1 diabetes using the Tandem Control-IQ hybrid closed-loop insulin delivery system spent significantly more time within their target blood glucose range than people using a sensor-augmented insulin pump during 6 months of use in the iDCL trial.
Implementing a nursing protocol that includes point-of-care testing at triage reduces the time to diabetic ketoacidosis diagnosis and the number of unnecessary intravenous placements in the pediatric emergency department, say researchers.
Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.
Children with type 1 diabetes have worse health outcomes and are more likely to miss school and have special educational needs than their nondiabetic peers, show results of a large study conducted in Scotland.
A retrospective analysis of clinical trial data indicates that regular eye examinations may not always be necessary for people younger than 18 years of age with type 1 diabetes, despite current recommendations to the contrary.
Approximately one-third of adolescents and young adults with type 1 diabetes display disturbed eating behavior that may be linked to worsening glycemic control and increasing depressive symptoms over time, research shows.